Tag: Phase 1 trial

Medical researcher holding vaccine vial in laboratory setting
New StudiesResearch Digest

First Lassa Fever Vaccine Shows Promise in Early Human Trial

First-in-human trial of dual rabies-Lassa fever vaccine shows promising safety and immune response results. The breakthrough could protect millions in…

By
GMJ Research Desk
Microscopic illustration of T cell engaging with cancer cell through bispecific antibody mechanism
Clinical UpdatesNew StudiesPracticeResearch Digest

MAGE-A4/MAGE-A8-Targeted Bispecific T Cell Engager Shows Promise in Refractory Solid Tumors

Novel bispecific T cell engager IMA401 targeting MAGE-A4/MAGE-A8 shows encouraging safety and preliminary efficacy in phase 1a trial. Early results…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →